Harve M. Blottiere

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Fifteen patients with metastatic gastrointestinal adenocarcinomas were treated with low doses of recombinant human interferon γ (rh-IFNγ) and a mixture of monoclonal antibodies (mAb) that bind to tumor cells. All antibodies were of the IgG2a isotype and interact with human effector cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC).(More)
  • 1